3B BLACKBIO DX Financial Statement Analysis
|
||
The Revenues of 3B BLACKBIO DX have decreased by -99.96% YoY .
The Earnings Per Share (EPS) of 3B BLACKBIO DX has decreased by -19.45 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
3B BLACKBIO DX Last 5 Annual Financial Results
[BOM: 532067]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹81 Cr | ₹226,742 Cr | ₹29 Cr | ₹23 Cr | ₹23 Cr |
Expenses | ₹44 Cr | ₹76,753 Cr | ₹20 Cr | ₹16 Cr | ₹18 Cr |
Operating Profit (Excl OI) | ₹37 Cr | ₹149,989 Cr | ₹9.32 Cr | ₹7.22 Cr | ₹5.43 Cr |
Other Income | ₹6.90 Cr | ₹2,892 Cr | ₹1.60 Cr | ₹0.74 Cr | ₹0.28 Cr |
Interest | ₹0.11 Cr | ₹228 Cr | ₹0.33 Cr | ₹0.46 Cr | ₹0.73 Cr |
Depreciation | ₹0.67 Cr | ₹616 Cr | ₹0.54 Cr | ₹0.55 Cr | ₹0.46 Cr |
Profit Before Tax | ₹43 Cr | ₹152,036 Cr | ₹10 Cr | ₹6.95 Cr | ₹4.52 Cr |
Profit After Tax | ₹32 Cr | ₹113,869 Cr | ₹7.69 Cr | ₹5.24 Cr | ₹3.43 Cr |
Consolidated Net Profit | ₹32 Cr | ₹113,869 Cr | ₹7.68 Cr | ₹5.24 Cr | ₹3.43 Cr |
Earnings Per Share (Rs) | ₹34.62 | ₹42.98 | ₹152.00 | ₹10.25 | ₹8.20 |
PAT Margin (%) | 41.94 | 39.93 | 50.22 | 26.62 | 22.52 |
ROE(%) | 16.00 | 22.59 | 138.73 | 28.15 | 28.99 |
ROCE(%) | 21.60 | 29.92 | 179.46 | 32.29 | 28.04 |
Total Debt/Equity(x) | 0.01 | 0.02 | 0.02 | 0.11 | 0.28 |
Key Financials |
||
Market Cap | : | ₹ 1,243.8 Cr |
Revenue (TTM) | : | ₹ 79.3 Cr |
Net Profit(TTM) | : | ₹ 36.2 Cr |
EPS (TTM) | : | ₹ 42.1 |
P/E (TTM) | : | 34.4 |
Industry Peers & Returns | 1W | 1M | 1Y |
3B BLACKBIO DX | 1.3% | 27.5% | 145.4% |
PI INDUSTRIES | 0.9% | 4.4% | 24.6% |
UPL | 1.7% | 11.7% | 2.6% |
BAYER CROPSCIENCE | 0.2% | -8.5% | 34.6% |
SUMITOMO CHEMICAL INDIA | 4.9% | 6.6% | 18.1% |
BASF INDIA | 4% | -2.2% | 154.6% |
3B BLACKBIO DX Revenues
[BOM: 532067]
Y-o-Y | -99.96 % |
5 Yr CAGR | 36.53 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹81 Cr | -99.96 | |
Mar2022 | ₹226,742 Cr | 785,153.07 | |
Mar2021 | ₹29 Cr | 24.05 | |
Mar2020 | ₹23 Cr | 0.28 | |
Mar2019 | ₹23 Cr | - |
3B BLACKBIO DX Operating Profit
[BOM: 532067]
Y-o-Y | -99.98 % |
5 Yr CAGR | 61.70 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹37 Cr | -99.98 | |
Mar2022 | ₹149,989 Cr | 1,609,567.29 | |
Mar2021 | ₹9.32 Cr | 29.06 | |
Mar2020 | ₹7.22 Cr | 33.04 | |
Mar2019 | ₹5.43 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -30.46 % |
5 Yr CAGR | 18.43 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 46% | -30.46 | |
Mar2022 | 66.15% | 104.99 | |
Mar2021 | 32.27% | 4.03 | |
Mar2020 | 31.02% | 32.68 | |
Mar2019 | 23.38% | - |
3B BLACKBIO DX Profit After Tax
[BOM: 532067]
Y-o-Y | -99.97 % |
5 Yr CAGR | 75.09 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹32 Cr | -99.97 | |
Mar2022 | ₹113,869 Cr | 1,483,149.29 | |
Mar2021 | ₹7.68 Cr | 46.45 | |
Mar2020 | ₹5.24 Cr | 53.01 | |
Mar2019 | ₹3.43 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 5.03 % |
5 Yr CAGR | 16.82 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 41.94 % | 5.03 | |
Mar2022 | 39.93 % | -20.49 | |
Mar2021 | 50.22 % | 88.66 | |
Mar2020 | 26.62 % | 18.21 | |
Mar2019 | 22.52 % | - |
3B BLACKBIO DX Earnings Per Share (EPS)
[BOM: 532067]
Y-o-Y | -19.45 % |
5 Yr CAGR | 43.34 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹35 | -19.45 | |
Mar2022 | ₹43 | -71.72 | |
Mar2021 | ₹152 | 1,382.93 | |
Mar2020 | ₹10 | 25.00 | |
Mar2019 | ₹8.20 | - |
3B BLACKBIO DX Return on Capital Employed (ROCE)
[BOM: 532067]
Y-o-Y | -27.81 % |
5 Yr CAGR | -6.32 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 21.6% | -27.81 | |
Mar2022 | 29.92% | -83.33 | |
Mar2021 | 179.46% | 455.78 | |
Mar2020 | 32.29% | 15.16 | |
Mar2019 | 28.04% | - |
3B BLACKBIO DX Share Price vs Sensex
Current Share Price | : | ₹1,446.3 |
Current MarketCap | : | ₹ 1,243.8 Cr |
Updated EOD on | : | Sep 06,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
3B BLACKBIO DX | 1.3% |
27.5% |
145.4% |
SENSEX | -1.4% |
3.3% |
25.2% |
3B BLACKBIO DX related INDICES
You may also like the below Video Courses
FAQ about 3B BLACKBIO DX Financials
How the annual revenues of 3B BLACKBIO DX have changed ?
The Revenues of 3B BLACKBIO DX have decreased by -99.96% YoY .
How the Earnings per Share (EPS) of 3B BLACKBIO DX have changed?
The Earnings Per Share (EPS) of 3B BLACKBIO DX has decreased by -19.45 % YoY .
Intrinsic Value of PI INDUSTRIES LTD Intrinsic Value of UPL LTD Intrinsic Value of BAYER CROPSCIENCE LTD Intrinsic Value of SUMITOMO CHEMICAL INDIA LTD Intrinsic Value of BASF INDIA LTD |
PI INDUSTRIES LTD vs UPL LTD vs BAYER CROPSCIENCE LTD
SUMITOMO CHEMICAL INDIA LTD vs BASF INDIA LTD vs